d-alpha tocopherol has been researched along with iloprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bozkurt, AK | 1 |
| Kobzar, G; Mardla, V; Samel, N | 1 |
3 other study(ies) available for d-alpha tocopherol and iloprost
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Alpha-tocopherol (Vitamin E) and iloprost attenuate reperfusion injury in skeletal muscle ischemia/reperfusion injury.
Topics: Animals; Antioxidants; Iloprost; Lipid Peroxidation; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vasodilator Agents; Vitamin E | 2002 |
Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
Topics: Adenosine Diphosphate; Adult; alpha-Tocopherol; Alprostadil; Blood Platelets; Dose-Response Relationship, Drug; Drug Synergism; Epoprostenol; Female; Humans; Iloprost; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins; Quercetin | 2004 |